Adverse reactions due to monoclonal antibodies in the treatment of allergic diseases. Group Positioning: Comité de Alergia a Medicamentos del Colegio Mexicano de Inmunología Clínica y Alergia (CMICA 2024-2025). Revista Alergia México, [S. l.], v. 72, n. 1, p. 52–71, 2025. DOI: 10.29262/fsaxnm03. Disponível em: https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/1433. Acesso em: 23 sep. 2026.